Nve CORP /NEW/

NVE Corporation announced an 81% revenue increase and a 79% net income jump for its first fiscal quarter, alongside a $1.00 per share dividend.

NVE Corporation announced robust financial results for the fourth quarter and full fiscal year ended March 31, 2026, with revenue and net income showing significant year-over-year increases, alongside a declared quarterly dividend.

NVE Corporation announced a 23% increase in third-quarter revenue and an 11% rise in net income, alongside a $1.00 per share quarterly cash dividend.

NVE Corporation has extended its key supplier partnering agreement with Abbott Laboratories through 2027, securing increased product pricing for 2026 and 2027.

NVE Corporation announced a 6% decrease in second-quarter revenue and an 18% drop in net income, while also approving a $1.00 per share quarterly cash dividend.

NVE Corporation shareholders approved all proposals at their 2025 Annual Meeting, including the re-election of five directors, advisory approval of executive compensation, and ratification of Boulay PLLP as independent auditor.

NVE Corporation announced a significant increase in revenue and net income for the first quarter of fiscal year 2027, driven by strong product sales and contract research and development.

NVE Corporation reported an 11% increase in net income for the third quarter of fiscal 2026, driven by robust product sales and contract research and development revenue, despite a lower gross margin.

NVE Corporation reported a 16.3% decrease in net income for the second quarter of fiscal 2026, driven by lower contract research and development revenue and reduced gross margins.

NVE Corporation reported a 10% decrease in total revenue and a 12.7% drop in net income for the first quarter of fiscal 2026, primarily driven by reduced product sales to the defense industry.

NVE Corporation's Q3 2025 results show a decrease in revenue and net income compared to the same period last year, primarily due to lower product sales and contract research revenue.

NVE Corporation's second quarter fiscal 2025 results show a decrease in revenue and an increase in expenses compared to the same period last year, despite a higher gross profit margin.

NVE Corp's fiscal year 2025 saw a decrease in revenue due to lower product sales, offset partially by increased contract research and development revenue, alongside a rise in research and development expenses.

NVE Corporation's fiscal year 2024 saw a decrease in revenue due to a semiconductor industry downturn, though the company maintained a strong balance sheet and continued to invest in product development.

Daniel A Baker, President & CEO and a Director of Nve Corp /New/, sold 20,000 shares of common stock on July 27, 2026.

Xuan Kelly Wei, a Director of Nve Corp /New/, reported multiple transactions in common stock on July 27, 2026.

NVE Corp President and CEO Daniel A. Baker was granted 2,500 incentive stock options as part of a compensation package.

NVE Corp's President and CEO, Daniel A. Baker, sold 1,258 shares of common stock in two transactions under a Rule 10b5-1 trading plan.

NVE Corp. Director James W. Bracke received 1,000 non-qualified stock options with an exercise price of $61.72, effective August 7, 2025, following his re-election to the Board.

NVE Corp. director Patricia M. Hollister received 1,000 non-qualified stock options with an exercise price of $61.72 following her re-election to the board.

NVE Corporation has filed a Definitive Proxy Statement Notice of Availability with the U.S. Securities and Exchange Commission.

NVE Corporation announced its 2025 Annual Meeting of Shareholders will be held on August 7, 2025, to elect five directors, approve executive compensation, and ratify its independent accounting firm.

NVE Corporation announced strong earnings for fiscal year 2025 despite a full-year revenue decrease, highlighting significant investments in R&D and capacity expansion for future growth.

NVE Corporation has announced its 2025 Annual Meeting of Shareholders, outlining proposals for director elections, executive compensation, and auditor ratification, while reporting a decrease in fiscal 2025 income from operations despite sequential revenue growth.

NVE Corporation has filed its definitive proxy statement with the SEC, signaling the upcoming shareholder meeting.

NVE Corporation will hold its Annual Meeting of Shareholders on August 1, 2024, to elect directors, approve executive compensation, and ratify the selection of its accounting firm.

Vanguard Capital Management has reported beneficial ownership of 5.02% of NVE Corp's common stock as of March 31, 2026.

Royce & Associates LP has filed a Schedule 13G, reporting beneficial ownership of 4.74% of NVE Corporation's common stock as of March 31, 2026.

The Vanguard Group reports 0% beneficial ownership in NVE Corp following an internal realignment and disaggregated reporting.

Investment adviser Royce & Associates LP has filed an amendment to its Schedule 13G, disclosing a 5.41% beneficial ownership stake in NVE Corporation's common stock.

Kayne Anderson Rudnick Investment Management, LLC has filed an amendment to its Schedule 13G, reporting a 4.5% beneficial ownership stake in NVE Corp as of September 30, 2025.

Royce & Associates LP has reported an increased beneficial ownership of 7.23% in NVE Corporation's common stock, holding 349,506 shares as of September 30, 2025.